What is Procaps Group?
Founded in 2021, Procaps Group operates as a comprehensive pharmaceutical and nutraceutical solutions provider with a global footprint spanning North America, South America, and Europe. The company is dedicated to the development and production of innovative healthcare products, including medicines and hospital supplies. Its strategic focus on international markets and advanced manufacturing capabilities positions it as a key player in the pharmaceutical industry, addressing diverse healthcare needs worldwide.
How much funding has Procaps Group raised?
Procaps Group has raised a total of $130M across 1 funding round:
Private Equity
$130M
Private Equity (2025): $130M with participation from Flying Fish Partners, Chemo, and Santana
Key Investors in Procaps Group
Flying Fish Partners
Flying Fish Partners is an early-stage venture capital firm based in Seattle, known for its focus on providing capital and support to high-potential AI and ML technology companies in the U.S. and Canada.
Chemo
Chemo is a global leader in the research, development, and manufacturing of active pharmaceutical ingredients and finished dosage forms, serving diverse therapeutic areas and offering contract manufacturing services.
Santana
Santana SA is a Chilean company operating within the banking sector, employing between 10 to 19 individuals and generating revenues between $10 million to $25 million.
What's next for Procaps Group?
The recent major strategic investment signals a pivotal phase for Procaps Group, likely aimed at accelerating its expansion into new markets, enhancing its research and development initiatives, and scaling its manufacturing operations. This capital injection is expected to fuel further innovation in pharmaceutical and nutraceutical solutions, reinforcing its competitive edge and solidifying its global presence. The company's commitment to developing cutting-edge healthcare products suggests a future focused on strategic acquisitions, technological advancements, and deeper penetration into key therapeutic areas.
See full Procaps Group company page
